-
1
المؤلفون: Fara Brasó-Maristany, Marta Guzman, Josep Tabernero, Mafalda Oliveira, Zighereda Ogbah, Judit Grueso, Maurizio Scaltriti, Mireia Parés, Aleix Prat, Oriol Casanovas, Elena Garralda, Jordi Rodon, Olga Rodriguez, Mònica Sánchez-Guixé, Cinta Hierro, Analia Azaro, Violeta Serra, Rodrigo Dienstmann, Paolo Nuciforo, Ana Vivancos, Cristina Saura, Erika Monelli, Mariona Graupera, Guillermo Villacampa, José Antonio Jiménez, Cristina Viaplana
المصدر: Clinical Cancer Research. 28:137-149
مصطلحات موضوعية: CD31, Cancer Research, medicine.diagnostic_test, business.industry, Angiogenesis, Kinase, Fibroblast growth factor receptor 1, medicine.disease, Immunofluorescence, Metastatic breast cancer, Breast cancer, Oncology, Cancer research, Medicine, Immunohistochemistry, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fc1a8b5bf78cd7165ed6c66557658b98
https://doi.org/10.1158/1078-0432.ccr-21-1810 -
2
المؤلفون: Jaid Landa, Cinta Hierro, Eva Muñoz-Couselo, Paolo Nuciforo, Joan Seoane, Cristina Viaplana, Joaquín Mateo, Marta Ligero, Ignacio Matos, Enriqueta Felip, Debora Gil, Elena Elez, Guillermo Villacampa, Carlota Rubio-Perez, Rodrigo Dienstmann, Joan Carles, Ana Oaknin, Elena Garralda, Josep Tabernero, Macarena Gonzalez, Raquel Perez-Lopez, Maria Ochoa-De-Olza, Juan Martin-Liberal, Alonso Garcia-Ruiz, Manuel Escobar, Cristina Suarez, Maria Vittoria Raciti, Rafael Morales-Barrera, Irene Brana, Roberta Fasani, Jordi Rodon
المصدر: Radiology
مصطلحات موضوعية: Male, business.industry, Immune checkpoint inhibitors, Middle Aged, Reviews and Commentary, Immune system, Radiomics, Neoplasms, Biomarkers, Tumor, Cancer research, Humans, Medicine, Female, Radiology, Nuclear Medicine and imaging, Tomography, X-Ray Computed, business, Immune Checkpoint Inhibitors, Aged, Retrospective Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84a0de5a0c23c801321f32a69b0bf48
https://doi.org/10.1148/radiol.2021200928 -
3
المؤلفون: Cinta Hierro, Hendrik-Tobias Arkenau, Lipika Goyal, Joon Oh Park, Funda Meric-Bernstam, Marc Sanson, Robin Kate Kelley, Yaohua He, Karim A. Benhadji, John Bridgewater, Milind Javle, Rastislav Bahleda, Ben Tran
المساهمون: Institut Català de la Salut, [Meric-Bernstam F] Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. [Bahleda R] Early Drug Development Department (DITEP), Gustave Roussy Cancer Center, Villejuif, France. [Hierro C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Sanson M] Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Epinière, and AP-HP Hôpitaux Universitaires La Pitié Salpêtrière Charles Foix, Service de Neurologie 2 Mazarin, Paris, France. [Bridgewater J] UCL Cancer Institute, London, United Kingdom. [Arkenau HT] Sarah Cannon Research Institute, HCA Healthcare, London, United Kingdom, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Other subheadings::Other subheadings::/antagonists & inhibitors [Other subheadings], Nausea, medicine.medical_treatment, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Targeted therapy, neoplasias [ENFERMEDADES], Hyperphosphatemia, Breast cancer, Factors de creixement fibroblàstic - Receptors - Inhibidors, medicine, Otros calificadores::Otros calificadores::/antagonistas & inhibidores [Otros calificadores], Adverse effect, Intrahepatic Cholangiocarcinoma, Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Peptide::Receptors, Growth Factor::Receptors, Fibroblast Growth Factor [CHEMICALS AND DRUGS], business.industry, aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores de péptidos::receptores de factores de crecimiento::receptores de factores de crecimiento de fibroblastos [COMPUESTOS QUÍMICOS Y DROGAS], Càncer - Tractament, Cancer, medicine.disease, Neoplasms [DISEASES], Clinical research, Oncology, Cancer research, medicine.symptom, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f30e7a5f313cb5684c095c734547b3
https://hdl.handle.net/11351/9694 -
4
المؤلفون: Monica Caro, Cinta Hierro, Ricard Mesia, Jose Luis Manzano, Cristina Buges, Laura Layos, Gabriela Antelo, Eduardo Baena, Juan Pablo Fernández
المصدر: Drugs in Context
Drugs in Context, Vol 9, Pp 1-13 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, targeted agents, medicine.medical_treatment, gastro-enteropancreatic neuroendocrine neoplasms, Review, Disease, chemotherapy, Systemic therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, neuroendocrine carcinomas, Neuroendocrine carcinoma, molecular alterations, radiotherapy, Pharmacology, Chemotherapy, business.industry, lcsh:RM1-950, Rare entity, General Medicine, Immunotherapy, Neuroendocrine Carcinomas, gastro-entero-pancreatic neuroendocrine neoplasms, Radiation therapy, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, immunotherapy, business, epigenetic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18bc737e3f10c639e0955526e88ff04e
https://doi.org/10.7573/dic.2020-2-4 -
5
المؤلفون: Teresa Macarulla, A. Pedrola, O. Saavedra, Javier Ros, Cristina Saura, Cristina Viaplana, Elena Garralda, R. Berché, Elena Elez, Enriqueta Felip, I. Gardeazabal, Maria Ochoa de Olza, Irene Brana, Rodrigo Dienstmann, Joan Carles, Juan Martin-Liberal, Guzman Alonso, Guillermo Villacampa, Jordi Rodon, Cinta Hierro, Eva Muñoz-Couselo, A. Hernando-Calvo, Analia Azaro, Maria Vieito, Vladimir Galvao, Josep Tabernero, Ignacio Matos, Ana Oaknin
المساهمون: Institut Català de la Salut, [Matos I, Carles J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Villacampa G, Berché R, Pedrola A, Viaplana C, Dienstmann R] Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Hierro C, Martin-Liberal J, Braña I, Azaro A, Vieito M, Saavedra O, Gardeazabal I, Hernando-Calvo A, Alonso G, Galvao V, Ochoa de Olza M, Ros J, Muñoz-Couselo E, Elez E, Rodon J, Saura C, Macarulla T, Oaknin A, Felip E, Garralda E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medicine, UVic-UCC, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Male, Oncology, Information Science::Informatics::Medical Informatics::Medical Informatics Applications [INFORMATION SCIENCE], Cancer Research, medicine.medical_specialty, Prognostic variable, Oncologia, Phases of clinical research, Ciencias de la información::informática::informática médica::aplicaciones de la informática médica [CIENCIA DE LA INFORMACIÓN], Medicina - Informàtica, Medical Oncology, Web tool, neoplasias [ENFERMEDADES], Patient Portals, Internal medicine, medicine, Humans, Selection (genetic algorithm), técnicas de investigación::métodos::diseño de la investigación::selección de los pacientes [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Aged, Clinical Trials as Topic, business.industry, Patient Selection, Middle Aged, Prognosis, Clinical trial, Neoplasms [DISEASES], Cohort, Prognostic model, Investigative Techniques::Methods::Research Design::Patient Selection [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Female, Early phase, business, Internet-Based Intervention, Assaigs clínics
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6c8e375a408516cff89589a7095f1b9
https://hdl.handle.net/11351/7702 -
6
المؤلفون: Osama E. Rahma, Darren W.T. Lim, Ravit Geva, Toshikiko Doi, A. Xyrafas, Philippe L. Bedard, Jennifer Marie Mataraza, Alexander M. Lesokhin, Javier Otero, Tira Jing Ying Tan, Angad P Singh, Xinhui Chen, Jason J. Luke, Lisa Nardi, Sarina Anne Piha-Paul, Cinta Hierro
المساهمون: Institut Català de la Salut, [Piha-Paul SA] Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [Geva R] Division of Oncology, Tel-Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel. [Tan TJ] Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada. [Lim DW] Division of Medical Oncology, National Cancer Centre Singapore, Singapore. [Hierro C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Molecular Therapeutics Research Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Doi T] Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan, Vall d'Hebron Barcelona Hospital Campus
المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Journal for Immunotherapy of Cancer
Scientiaمصطلحات موضوعية: Male, Cancer Research, Lymphoma, Colorectal cancer, Gastroenterology, Antineoplastic Agents, Immunological, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, antibodies, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, clinical trials as topic, Càncer - Tractament, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoplasms::Neoplasms by Histologic Type::Lymphoma [DISEASES], Middle Aged, drug therapy, Oncology, Tolerability, Response Evaluation Criteria in Solid Tumors, Molecular Medicine, Adenocarcinoma, Female, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Immunology, therapies, neoplasias::neoplasias por tipo histológico::linfoma [ENFERMEDADES], investigational, Antibodies, Monoclonal, Humanized, Quimioteràpia combinada, neoplasias [ENFERMEDADES], Pharmacokinetics, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Glucocorticoid-Induced TNFR-Related Protein, medicine, Humans, Adverse effect, Aged, Pharmacology, combination, Dose-Response Relationship, Drug, business.industry, Endometrial cancer, Cancer, medicine.disease, Neoplasms [DISEASES], business, neoplasm
وصف الملف: application/pdf
-
7
المؤلفون: Cinta Hierro, Alain C. Mita, Andrés Cervantes, Mark M. Awad, Josep Tabernero, Italo Poggesi, Rastilav Bahleda, Victor Moreno, Nancy Chan, Antoine Italiano, Ademi E. Santiago-Walker, Trilok V. Parekh, Emiliano Calvo, Jeffrey R. Infante, Alexander I. Spira, Ramaswamy Govindan, Bob Zhong, Martha Gonzalez, Hong Xie
المصدر: Clinical Cancer Research. 25:4888-4897
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Administration, Oral, Antineoplastic Agents, Drug resistance, Gastroenterology, Young Adult, 03 medical and health sciences, Hyperphosphatemia, 0302 clinical medicine, Refractory, Erdafitinib, Neoplasms, Quinoxalines, Internal medicine, medicine, Humans, Neoplasm, Dosing, Adverse effect, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Genetic Variation, Middle Aged, Prognosis, medicine.disease, Receptors, Fibroblast Growth Factor, Treatment Outcome, 030104 developmental biology, Oncology, Tolerability, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Retreatment, Pyrazoles, Female, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfe6f93ed74fb1ed356ecce6401a4f2b
https://doi.org/10.1158/1078-0432.ccr-18-3334 -
8
المصدر: Clinical Cancer Research. 25:3210-3219
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, United States Food and Drug Administration, Clinical study design, MEDLINE, Antineoplastic Agents, Context (language use), Pembrolizumab, Antibodies, Monoclonal, Humanized, Precision medicine, United States, Translational Research, Biomedical, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Drug Development, Oncology, Risk analysis (engineering), 030220 oncology & carcinogenesis, Humans, Relevance (law), Molecular Profile, Business, Drug Approval, Reimbursement
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5124a4a6c87caea7c698442485ea7f
https://doi.org/10.1158/1078-0432.ccr-18-3694 -
9
المؤلفون: Claudio Zanna, Cinta Hierro, A. John Iafrate, Josep Tabernero, Rebecca S. Heist, Nobuya Ishii, Funda Meric-Bernstam, Valerie Nicolas-Metral, James M. Cleary, Anna Pokorska-Bocci, Keith T. Flaherty, Martin H. Voss, Yulia Kirpicheva, Anne Vaslin Chessex, Leena Gandhi, José Baselga, Youyou Hu, Filip Janku, Darrell R. Borger
المصدر: Clinical Cancer Research. 25:2699-2707
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, business.industry, medicine.disease, Gastroenterology, 03 medical and health sciences, Hyperphosphatemia, 030104 developmental biology, 0302 clinical medicine, Oncology, Tolerability, Pharmacokinetics, 030220 oncology & carcinogenesis, Pharmacodynamics, Internal medicine, Toxicity, medicine, FGFR Inhibitor Debio 1347, Adverse effect, business, Stomatitis
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bd20b4b8a8df971c52c00aad68267c94
https://doi.org/10.1158/1078-0432.ccr-18-1959 -
10
المؤلفون: Sukrut Shah, Vladimir Kostorov, Lee Anne McLean, Takashi Kojima, Jong-Mu Sun, Ying Zhu, Manish A. Shah, Lin Shen, Mustafa Ozguroglu, Antoine Adenis, Toshihiko Doi, Peter C. Enzinger, Ken Kato, Byoung Chul Cho, Cinta Hierro, Jaafar Bennouna
المساهمون: İÜC, Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
المصدر: Future Oncology. 15:1057-1066
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Esophageal Neoplasms, esophagogastric junction cancer, medicine.medical_treatment, Pembrolizumab, gastrointestinal/esophageal, chemotherapy, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, PD-1, Advanced esophageal cancer, esophageal cancer, squamous cell carcinoma of the esophagus, Aged, 80 and over, biology, General Medicine, Middle Aged, Esophageal cancer, Prognosis, Survival Rate, Research Design, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Fluorouracil, immunotherapy, pembrolizumab, Adult, PD-L1, medicine.medical_specialty, Adolescent, Antibodies, Monoclonal, Humanized, Young Adult, 03 medical and health sciences, Double-Blind Method, Internal medicine, medicine, Humans, Aged, Chemotherapy, business.industry, Cancer, Immunotherapy, medicine.disease, Clinical trial, 030104 developmental biology, biology.protein, business, Follow-Up Studies
وصف الملف: application/pdf